Peptide Regulations Are Changing…What Now? | Legal 123s with ByrdAdatto

Everyone is talking about the recent peptide updates, but has anything actually changed? In this episode, Partner Samuel Pondrom breaks down the latest recommendations from the FDA advisory committee involving six popular peptides (BPC-157, KPV, TB-500, MOTS-C, Epitalon, and Semax). Learn why these recommendations are only one step in the regulatory process, and why state law, patient-specific prescriptions, reliable sourcing, and accurate marketing still matter. Discover how practices navigate emerging peptide services without mistaking regulatory movement for a green light. Timestamps: 00:00 Intro 01:42 Banter 04:43 Story 26:09 Access+ 26:48 Legal Takeaways 30:28 Outro LAST WEEK'S EPISODE:    • I Am Hiring My First Injector…What Now? | ...   LISTEN TO FULL EPISODES OF OUR PODCAST: https://byrdadatto.com/podcast/#page=1 SUBSCRIBE TO OUR YOUTUBE CHANNEL:    / @byrdadatto   FOLLOW US ON SOCIAL: Facebook:   / byrdadatto   Instagram:   / byrdadattolaw   LinkedIn:   / byrdadatto   X:   / byrdadatto